One patent covers implantable devices made with a thermoplastic polymer such as polyetheretherketone, at least one region with interconnected porosity and bioactive particles, according to a news release. The other protects a manufacturing process for implants involving thermoplastic polymers with regions of differing porosity.
Happe’s proprietary material has interconnected, cancellous porosity and bioactive surfaces with exposed hydroxyapatite for bone in-growth and on-growth.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.